# Livent USA Corp – FDA Inspection, Feb 16, 2018

Source: https://www.keypedia.com/records/fda_inspections/livent-usa-corp/8dfce843-44a5-4d8f-b239-8455a4a47457
Source feed: FDA_Inspections

> FDA inspection 1041263 of Livent USA Corp, February 16, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 5 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1041263
- Company Name: Livent USA Corp
- Inspection Date: 2018-02-16
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1287458 - 2025-09-11
- FDA Inspection 1117376 - 2020-02-07
- FDA Inspection 988689 - 2016-09-27
- FDA Inspection 830070 - 2013-05-02
- FDA Inspection 658633 - 2010-04-20

## Related Officers

- [Company Rep](https://www.keypedia.com/people/larry-k-hampton/de10767b-b25b-4d55-bfe2-60ea51c828f6)

Company: https://www.keypedia.com/companies/livent-usa-corp/62a57fac-fd3b-417b-bcfb-cf0122756768

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
